Mantzaris GJ - Search Results

1

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.

Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. Bressler B, et al. Among authors: mantzaris gj. J Crohns Colitis. 2021 Oct 7;15(10):1694-1706. doi: 10.1093/ecco-jcc/jjab058. J Crohns Colitis. 2021. PMID: 33786600 Free PMC article.

2

Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists.

Chowers Y, Sturm A, Sans M, Papadakis K, Gazouli M, Harbord M, Jahnel J, Mantzaris GJ, Meier J, Mottet C, Peyrin-Biroulet L, Allez M. Chowers Y, et al. Among authors: mantzaris gj. J Crohns Colitis. 2010 Oct;4(4):367-76. doi: 10.1016/j.crohns.2010.05.011. Epub 2010 Jul 1. J Crohns Colitis. 2010. PMID: 21122531

3

The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease.

Mantzaris GJ, Roussos A, Christidou A, Koilakou S, Kalantzis CN, Petraki K, Sfakianakis M, Karagiannidis A, Polyzou P. Mantzaris GJ, et al. J Crohns Colitis. 2007 Sep;1(1):28-34. doi: 10.1016/j.crohns.2007.06.002. J Crohns Colitis. 2007. PMID: 21172181

4

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.

Katz L, Gisbert JP, Manoogian B, Lin K, Steenholdt C, Mantzaris GJ, Atreja A, Ron Y, Swaminath A, Shah S, Hart A, Lakatos PL, Ellul P, Israeli E, Svendsen MN, van der Woude CJ, Katsanos KH, Yun L, Tsianos EV, Nathan T, Abreu M, Dotan I, Lashner B, Brynskov J, Terdiman JP, Higgins PD, Chaparro M, Ben-Horin S. Katz L, et al. Among authors: mantzaris gj. Inflamm Bowel Dis. 2012 Nov;18(11):2026-33. doi: 10.1002/ibd.22902. Epub 2012 Jan 31. Inflamm Bowel Dis. 2012. PMID: 22294554 Free article.

5

Circulating MicroRNA in inflammatory bowel disease.

Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Paraskevi A, et al. J Crohns Colitis. 2012 Oct;6(9):900-4. doi: 10.1016/j.crohns.2012.02.006. Epub 2012 Feb 28. J Crohns Colitis. 2012. PMID: 22386737

6

Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.

Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. Papamichael K, et al. Among authors: mantzaris gj. J Crohns Colitis. 2012 Oct;6(9):924-31. doi: 10.1016/j.crohns.2012.02.012. Epub 2012 Mar 15. J Crohns Colitis. 2012. PMID: 22424843 Clinical Trial.

7

Faecal calprotectin but not C-reactive protein (CRP) or Crohn's Disease Activity Index (CDAI) may predict post-operative endoscopic recurrence of Crohn's disease.

Papamichael K, Karatzas P, Mantzaris GJ. Papamichael K, et al. Among authors: mantzaris gj. J Crohns Colitis. 2013 Dec;7(12):e700-1. doi: 10.1016/j.crohns.2013.07.008. Epub 2013 Aug 13. J Crohns Colitis. 2013. PMID: 23953238 No abstract available.

8

Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.

Cesarini M, Katsanos K, Papamichael K, Ellul P, Lakatos PL, Caprioli F, Kopylov U, Tsianos E, Mantzaris GJ, Ben-Horin S, Danese S, Fiorino G. Cesarini M, et al. Among authors: mantzaris gj. Dig Liver Dis. 2014 Feb;46(2):135-9. doi: 10.1016/j.dld.2013.10.007. Epub 2013 Nov 15. Dig Liver Dis. 2014. PMID: 24246151

9

DNA methylation profile of genes involved in inflammation and autoimmunity in inflammatory bowel disease.

Karatzas PS, Mantzaris GJ, Safioleas M, Gazouli M. Karatzas PS, et al. Among authors: mantzaris gj. Medicine (Baltimore). 2014 Dec;93(28):e309. doi: 10.1097/MD.0000000000000309. Medicine (Baltimore). 2014. PMID: 25526479 Free PMC article.

10

Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease.

Papamichael K, Karatzas P, Mantzaris GJ. Papamichael K, et al. Among authors: mantzaris gj. J Crohns Colitis. 2015 Jul;9(7):589-90. doi: 10.1093/ecco-jcc/jjv062. Epub 2015 Apr 11. J Crohns Colitis. 2015. PMID: 25863276 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page